Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) I

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2025

Conditions
Treatment-resistant Depression
Interventions
DRUG

Propofol

Targeted propofol infusion in TRD patients will induce sedation with maximal expression of EEG slow waves and minimal burst suppression.

DIAGNOSTIC_TEST

Electroencephalography (EEG)

EEG will be recorded during propofol infusion and during overnight sleep. Sleep EEG data will be acquired for a minimum of one night prior to the first sedation session, providing a baseline measure. Additional overnight sleep recordings will be performed on day of sedation and subsequent nights.

DIAGNOSTIC_TEST

Slow-Wave Activity

Duration of slow waves during sedation will be evaluated using automated approaches. SWA during sedation will be calculated as the total power in the 0.5-4 Hz frequency band/total time in minutes. SWA during N2/N3 sleep will be calculated as the total power in the 0.5-4 Hz frequency band/total time in minutes in the N2 and N3 sleep stages. Delta sleep ratio will be computed from the SWA measured during the first and second N2/N3 cycles.

Trial Locations (1)

63110

Washington University School of Medicine/Barnes-Jewish Hospital, St Louis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER